1. Michael J,Sofia 美国 Arbutus Biopharma Incorporated 2016拉斯克奖 Checkpoint inhibition through small molecule-induced internalization of programmed death-ligand 1
2. Weichselbaum, Ralph R. 美国 The University of Chicago 1997美国医学院院士 Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance
3. James A. Wells 美国 University of California, San Francisco 1999美国科学院院士 Extracellular targeted protein degradation: an emerging modality for drug discovery
4. James A. Wells 美国 University of California, San Francisco 1999美国科学院院士 Biotin as a Reactive Handle to Selectively Label Proteins and DNA with Small Molecules
5. Chiocca, E. Antonio 美国 Harvard Medical School 2014美国医学院院士 Specific targeting of glioblastoma with an oncolytic virus expressing a cetuximab-CCL5 fusion protei..
6. Caligiuri, Michael A. 美国 The Ohio State University 2018美国医学院院士 Specific targeting of glioblastoma with an oncolytic virus expressing a cetuximab-CCL5 fusion protei..
7. 曹雪涛 中国 国家卫生健康委员会 2017美国医学院院士;中国工程院院士 Antibody variable region engineering for improving cancer immunotherapy
8. James A. Wells 美国 University of California, San Francisco 1999美国科学院院士 Roadmap for Optimizing and Broadening Antibody-Based PROTACs for Degradation of Cell Surface Protein..
9. Giaccia, Amato J. 美国 Stanford University School of Medicine 2015美国医学院院士 Neutralization of PD-L2 is Essential for Overcoming Immune Checkpoint Blockade Resistance in Ovarian..
10. James A. Wells 美国 University of California, San Francisco 1999美国科学院院士 Development of Antibody-Based PROTACs for the Degradation of the Cell-Surface Immune Checkpoint Prot..
11. 黄建 中国 浙江大学 Efficacy and safety of KN026 and docetaxel for HER2-positive breast cancer: a phase II clinical tria..
12. 张清媛 中国 哈尔滨医科大学 Efficacy and safety of KN026 and docetaxel for HER2-positive breast cancer: a phase II clinical tria..
13. 沈琳 中国 北京大学 主任医师 Efficacy and safety of KN026, a bispecific anti-HER2 antibody, in combination with KN046, an anti-CT..
14. Park, Chul-Kee 韩国 Seoul National University SNUH methylation classifier for CNS tumors
15. Park, Sung-Hye 韩国 Seoul National University SNUH methylation classifier for CNS tumors
16. Omar,Abdel-Rahman 加拿大 University of Alberta Multidisciplinary Canadian consensus on the multimodal management of high-risk and radioactive iodin..
17. Shereen,Ezzat 加拿大 University of Toronto Multidisciplinary Canadian consensus on the multimodal management of high-risk and radioactive iodin..
18. Jay H,Ryu 美国 Mayo Clinic - Rochester What Is on the Horizon for Treatments in Idiopathic Pulmonary Fibrosis?
19. 何川 美国 University of Chicago Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance
20. 傅阳心 中国 清华大学 Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance